Investing

Investment Purchases

Edwards Lifesciences Investment Purchases decreased by 22.4% to $641.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.0%, from $634.50M to $641.10M. Over 4 years (FY 2021 to FY 2025), Investment Purchases shows an upward trend with a 17.4% CAGR.

Analysis

StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2020
Last reportedQ4 2025

How to read this metric

An increase indicates a surplus of cash being deployed into financial markets rather than core operations; a decrease may suggest a need for liquidity.

Detailed definition

The total cash outflow for the acquisition of debt and equity securities, including marketable securities and other fina...

Peer comparison

Large-cap technology firms often show high outflows here as they manage massive cash reserves across global portfolios.

Metric ID: purchases_of_investments

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$299.10M$345.50M$907.30M$74.10M$40.20M$188.50M$13.00M$3.20M$3.60M$1.60M$700.00K$1.80M$0.00$517.00M$381.10M$634.50M$624.30M$1.01B$826.60M$641.10M
QoQ Change+15.5%+162.6%-91.8%-45.7%+368.9%-93.1%-75.4%+12.5%-55.6%-56.3%+157.1%-100.0%-26.3%+66.5%-1.6%+61.2%-17.9%-22.4%
YoY Change-86.6%-45.4%-98.6%-95.7%-91.0%-99.2%-94.6%-43.8%-100.0%>999%>999%>999%+94.7%+116.9%+1.0%
Range$0.00$1.01B
CAGR+17.4%
Avg YoY Growth>999%
Median YoY Growth-45.4%
Current Streak2 quarters decline

Frequently Asked Questions

What is Edwards Lifesciences's investment purchases?
Edwards Lifesciences (EW) reported investment purchases of $641.10M in Q1 2026.
How has Edwards Lifesciences's investment purchases changed year-over-year?
Edwards Lifesciences's investment purchases increased by 1.0% year-over-year, from $634.50M to $641.10M.
What is the long-term trend for Edwards Lifesciences's investment purchases?
Over 4 years (2021 to 2025), Edwards Lifesciences's investment purchases has grown at a 17.4% compound annual growth rate (CAGR), from $1.63B to $3.09B.
What does investment purchases mean?
The amount of money a company spent to buy stocks, bonds, or other investment securities.